AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Exchange Rate Effect came in at -$276000.0 in Q1 2026, down 962.5% year-on-year from $32000.0 in Q1 2025, and down 962.5% quarter-over-quarter from $32000.0 in Q1 2025.
AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Exchange Rate Effect data on file, last reported at -$468000.0 in Q3 2025.
- For the quarter ending Q3 2025, Exchange Rate Effect fell 297.47% year-over-year to -$468000.0; the trailing twelve-month figure through Sep 2025 stood at -$107000.0 (down 496.3% YoY), and the FY2024 full-year result was $362000.0, up 91.53% from the prior year.
- Exchange Rate Effect eased to -$276000.0 in Q1 2026 per ATAI's latest filing, from $32000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $32000.0 in Q1 2025 and bottomed at -$276000.0 in Q1 2026.
- A 5-year average of -$59052.6 and a median of $66000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 3141.18% in 2022 and surged 212.12% in 2025, its largest moves.
- Tracing ATAI's Exchange Rate Effect over 5 years: stood at -$17000.0 in 2021, then sank by 3141.18% to -$551000.0 in 2022, then soared by 61.52% to -$212000.0 in 2023, then surged by 158.02% to $123000.0 in 2024, then plunged by 480.49% to -$468000.0 in 2025.
- Business Quant data shows ATAI's Exchange Rate Effect at -$468000.0 in Q3 2025, $206000.0 in Q2 2025, and $32000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -468,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276,000.00 |
| Mar 31, 2026 | -276,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Dec 31, 2023 | -212,000.00 |
| Dec 31, 2023 | -212,000.00 |